Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia

Giovanni D'Arena; Silvestro Volpe; Rachele Amodeo; Virginia Tirino; Fiorella D'Auria; Giordano Annamaria; Giuseppe Pietrantuono; Luca Laurenti; Antonella Aiello; Pellegrino Musto

doi:10.1111/ijlh.13766

Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia

Giovanni D'Arena
, Silvestro Volpe
, Rachele Amodeo
, Virginia Tirino
, Fiorella D'Auria
, Giordano Annamaria
, Giuseppe Pietrantuono
, Luca Laurenti
, Antonella Aiello
, Pellegrino Musto

ASL Salerno
Azienda Ospedaliera S.G. Moscati
Sant'Andrea Hospital
University of Campania Luigi Vanvitelli
IRCCS Centro di riferimento oncologico della Basilicata - Rionero in Vulture (PZ)
AOUC Policlinico
IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
University of Bari

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

/

Lingua originale	Inglese
pagine (da-a)	e120-e122
Rivista	International Journal of Laboratory Hematology
Volume	44
DOI	https://doi.org/10.1111/ijlh.13766
Stato di pubblicazione	Pubblicato - 2022

Keywords

chronic lymphocytic leukemia
flow cytometry
minimal residual disease
prognosis
standardization

Accesso al documento

10.1111/ijlh.13766

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

D'Arena, G., Volpe, S., Amodeo, R., Tirino, V., D'Auria, F., Annamaria, G., Pietrantuono, G., Laurenti, L., Aiello, A., & Musto, P. (2022). Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia. International Journal of Laboratory Hematology, 44, e120-e122. https://doi.org/10.1111/ijlh.13766

@article{edf7f50465d24940a0f5c310421954df,

title = "Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia",

abstract = "/",

keywords = "chronic lymphocytic leukemia, flow cytometry, minimal residual disease, prognosis, standardization, chronic lymphocytic leukemia, flow cytometry, minimal residual disease, prognosis, standardization",

author = "Giovanni D'Arena and Silvestro Volpe and Rachele Amodeo and Virginia Tirino and Fiorella D'Auria and Giordano Annamaria and Giuseppe Pietrantuono and Luca Laurenti and Antonella Aiello and Pellegrino Musto",

year = "2022",

doi = "10.1111/ijlh.13766",

language = "English",

volume = "44",

pages = "e120--e122",

journal = "International Journal of Laboratory Hematology",

issn = "1751-553X",

publisher = "John Wiley and Sons Inc.",

}

D'Arena, G, Volpe, S, Amodeo, R, Tirino, V, D'Auria, F, Annamaria, G, Pietrantuono, G, Laurenti, L, Aiello, A & Musto, P 2022, 'Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia', International Journal of Laboratory Hematology, vol. 44, pagg. e120-e122. https://doi.org/10.1111/ijlh.13766

TY - JOUR

T1 - Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia

AU - D'Arena, Giovanni

AU - Volpe, Silvestro

AU - Amodeo, Rachele

AU - Tirino, Virginia

AU - D'Auria, Fiorella

AU - Annamaria, Giordano

AU - Pietrantuono, Giuseppe

AU - Laurenti, Luca

AU - Aiello, Antonella

AU - Musto, Pellegrino

PY - 2022

Y1 - 2022

N2 - /

AB - /

KW - chronic lymphocytic leukemia

KW - flow cytometry

KW - minimal residual disease

KW - prognosis

KW - standardization

KW - chronic lymphocytic leukemia

KW - flow cytometry

KW - minimal residual disease

KW - prognosis

KW - standardization

UR - http://hdl.handle.net/10807/235470

U2 - 10.1111/ijlh.13766

DO - 10.1111/ijlh.13766

M3 - Article

SN - 1751-553X

VL - 44

SP - e120-e122

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

ER -

Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo